Main Products & Services Platforms
▪ Startup specializing in 3D digital pathology and AI for clinical diagnoses. ▪ Develops 3D AI models for spatial recognition in cancers (lung, prostate, breast, head and neck, and colorectal, etc.). ▪ Compatible with fresh and FFPE tissues; enhances pathology workflows. ▪ Supports H&E, IHC, genetic tests, and a Panoramic Pathology Platform for tumor analysis. ▪ Coverage of Biomarker: Her2, PD-L1, Ki-67, ER, PR, panCK, TTF1, EGFR, PD-L1, CD3, CD4, CD8, CD20, CD31, CD45 ▪ JelloX MetaLite: CPU-based edge AI, Intel Market Ready Solution. ▪ Partners with Roche Diagnostic and Intel for an AI+federated learning digital pathology platform. ▪ Closely working with Mayo clinical, National cancer center East hospital, Erasmus university, Rotterdam Medical center ▪ Aims to revolutionize smart hospitals and labs; seeks global partnerships for expansion.
Business Interests
In-/Out-Licensing, Collaborative R&D, and Collaborative new drug development.
Contact Info
Servina Liu
CBO
+1-925-667-7687
servina_liu@jellox.com